← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

5,215

Price

$0

Filed

Feb 13

Insider

Name

German Christopher Paul

Title

Corporate Controller & CAO

CIK

0001260835

Roles

Officer

Transaction Details

Transaction Date

2026-02-11

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

5,215

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. | The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date.

Filing Info

Accession No.

0001104659-26-015398

Form Type

4

Issuer CIK

0001649904

German Christopher Paul's History

Date Ticker Type Value
2026-03-04 RYTM M $27K
2026-03-04 RYTM $503K
2026-03-04 RYTM M $0
2026-03-01 RYTM M
2026-03-01 RYTM F $32K
2026-03-01 RYTM M $0
2026-02-11 RYTM A $0
2026-02-01 RYTM M
2026-02-01 RYTM F $124K
2026-02-01 RYTM M $0

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
$503K 2026-03-04
Mathers Edward T 2026-03-02
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-11
Smith Hunter C
Chief Financial Officer
$2.2M 2026-03-02
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-11
Cramer Pamela J.
Chief Human Resources Officer
2026-02-11
Shulman Joseph
Chief Technical Officer
2026-02-11
Garfield Alastair
Chief Scientific Officer
2026-02-11